Halozyme Therapeutics reported a GAAP net profit of $335.94 million for 9M 2021, up 6 times from $55.921 million in the previous year. Revenues increased 2.3 times to $341.307 million from $145.891 million a year earlier.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept